AlphaQuest’s Evolent Health EVH Stock Holding History

AlphaQuest’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-74,838	Closed	-$299K	–	683
2025 Q4	$299K	Buy	74,838 +31,338	+72%	+$174K	0.02%	1213
2025 Q3	$368K	Buy	43,500 +35,662	+455%	+$346K	0.02%	1011
2025 Q2	$88.3K	Sell	7,838 -9,226	-54%	-$84.7K	0.01%	1471
2025 Q1	$162K	Buy	17,064 +14,019	+460%	+$142K	0.02%	1085
2024 Q4	$34.3K	Buy	3,045 +3,031	+21,650%	+$53.3K	﹤0.01%	1358
2024 Q3	$396	Sell	14 -4,520	-100%	-$117K	﹤0.01%	1754
2024 Q2	$86.7K	Buy	+4,534	New	+$116K	0.01%	966

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AlphaQuest's EVH Position: Q1 2026 in Review

AlphaQuest sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 74,838 shares — an estimated $299K sold.

AlphaQuest first reported a position in EVH in Q2 2024 and held it in 7 quarters. The position peaked at $368K in Q3 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

AlphaQuest reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 74,838 Evolent Health shares in Q1 2026, an estimated $299K.
AlphaQuest first reported a position in Evolent Health in Q2 2024 and held it in 7 quarters.
AlphaQuest's Evolent Health position peaked at $368K in Q3 2025.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.